Trial intelligence / Profile preview

Cobiprostone in Portal Hypertension

NCT00737594Phase 2Terminated

Sponsor
Sucampo
Start
Jul 2008
Primary completion
Feb 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of cobiprostone in Portal Hypertension (PH), sponsored by Sucampo. Started Jul 2008; status: terminated.

02

Drugs

cobiprostone
03

Conditions

Portal Hypertension (PH)

Beyond the preview

Go deeper on NCT00737594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00737594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call